|
Name |
1,4-Diethylbenzene
|
Molecular Formula | C10H14 | |
IUPAC Name* |
1,4-diethylbenzene
|
|
SMILES |
CCC1=CC=C(C=C1)CC
|
|
InChI |
InChI=1S/C10H14/c1-3-9-5-7-10(4-2)8-6-9/h5-8H,3-4H2,1-2H3
|
|
InChIKey |
DSNHSQKRULAAEI-UHFFFAOYSA-N
|
|
Synonyms |
1,4-DIETHYLBENZENE; 105-05-5; p-Diethylbenzene; Benzene, 1,4-diethyl-; p-Ethylethylbenzene; Benzene, p-diethyl-; para-Diethylbenzene; 1,4-diethyl-benzene; 0PSM16X42D; CHEBI:34062; HSDB 4083; EINECS 203-265-2; UNII-0PSM16X42D; DSSTox_CID_6711; DIETHYLBENZENE, P-; EC 203-265-2; DSSTox_RID_78192; DSSTox_GSID_26711; 1,4-Diethylbenzene, 96%; BIDD:ER0274; DIETHYLBENZENE, 1,4-; CHEMBL3187283; DTXSID4026711; 1,4-DIETHYLBENZENE [HSDB]; ZINC2013555; p-Diethylbenzene 1,4-Diethylbenzene; Tox21_200146; MFCD00009264; AKOS009031101; 1,4-Diethylbenzene, analytical standard; NCGC00248539-01; NCGC00257700-01; AS-13583; CAS-105-05-5; D0479; FT-0606869; EN300-21456; 1,4-Diethylbenzene 100 microg/mL in Methanol; D88164; Q-200084; Q27115785
|
|
CAS | 105-05-5 | |
PubChem CID | 7734 | |
ChEMBL ID | CHEMBL3187283 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 134.22 | ALogp: | 3.5 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 10 | QED Weighted: | 0.579 |
Caco-2 Permeability: | -4.243 | MDCK Permeability: | 0.00001950 |
Pgp-inhibitor: | 0.047 | Pgp-substrate: | 0.007 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.259 |
30% Bioavailability (F30%): | 0.922 |
Blood-Brain-Barrier Penetration (BBB): | 0.813 | Plasma Protein Binding (PPB): | 94.75% |
Volume Distribution (VD): | 1.457 | Fu: | 2.61% |
CYP1A2-inhibitor: | 0.98 | CYP1A2-substrate: | 0.921 |
CYP2C19-inhibitor: | 0.895 | CYP2C19-substrate: | 0.549 |
CYP2C9-inhibitor: | 0.728 | CYP2C9-substrate: | 0.289 |
CYP2D6-inhibitor: | 0.885 | CYP2D6-substrate: | 0.314 |
CYP3A4-inhibitor: | 0.118 | CYP3A4-substrate: | 0.567 |
Clearance (CL): | 10.317 | Half-life (T1/2): | 0.379 |
hERG Blockers: | 0.119 | Human Hepatotoxicity (H-HT): | 0.053 |
Drug-inuced Liver Injury (DILI): | 0.128 | AMES Toxicity: | 0.032 |
Rat Oral Acute Toxicity: | 0.028 | Maximum Recommended Daily Dose: | 0.058 |
Skin Sensitization: | 0.452 | Carcinogencity: | 0.217 |
Eye Corrosion: | 0.961 | Eye Irritation: | 0.992 |
Respiratory Toxicity: | 0.131 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002242 | 0.422 | D06CDO | 0.356 | ||||
ENC000305 | 0.400 | D0W1RY | 0.341 | ||||
ENC000413 | 0.395 | D0YQ5L | 0.314 | ||||
ENC000203 | 0.378 | D0R1QE | 0.308 | ||||
ENC000350 | 0.366 | D0K1QD | 0.304 | ||||
ENC000223 | 0.366 | D02HXS | 0.304 | ||||
ENC000740 | 0.366 | D0B3QM | 0.300 | ||||
ENC000612 | 0.349 | D02AQY | 0.294 | ||||
ENC000908 | 0.345 | D08GYO | 0.286 | ||||
ENC000310 | 0.341 | D01CRB | 0.286 |